Targeting of topoisomerases for prognosis and drug resistance in ovarian cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1757-2215
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Targeting of topoisomerases for prognosis and drug resistance in ovarian cancer ; volume:9 ; number:1 ; day:18 ; month:6 ; year:2016 ; pages:1-12 ; date:12.2016
Journal of ovarian research ; 9, Heft 1 (18.6.2016), 1-12, 12.2016
- Urheber
-
Bai, Yang
- Beteiligte Personen und Organisationen
-
Li, Liang-Dong
Li, Jun
Lu, Xin
SpringerLink (Online service)
- DOI
-
10.1186/s13048-016-0244-9
- URN
-
urn:nbn:de:1111-2016061910652
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bai, Yang
- Li, Liang-Dong
- Li, Jun
- Lu, Xin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Prognostic values of S100 family members in ovarian cancer patients
Long noncoding RNA C17orf91 is a potential prognostic marker and functions as an oncogene in ovarian cancer
DNA methylation-based profiling reveals distinct clusters with survival heterogeneity in high-grade serous ovarian cancer
Quantifying Patterns in Mortuary Practices: An Application of Factor Analysis and Cluster Analysis to Data From the Taosi Site, China
The prognostic significance of anti-angiogenesis therapy in ovarian cancer: a meta-analysis
Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience
Patients with low nicotinamide N-methyltransferase expression benefit significantly from bevacizumab treatment in ovarian cancer
Development and validation of SIRT3-related nomogram predictive of overall survival in patients with serous ovarian cancer
SCIPAC: quantitative estimation of cell-phenotype associations
The prognostic value of ITGA and ITGB superfamily members in patients with high grade serous ovarian cancer
Gene signature characteristic of elevated stromal infiltration and activation is associated with increased risk of hematogenous and lymphatic metastasis in serous ovarian cancer
The epigenetic factor CHD4 contributes to metastasis by regulating the EZH2/β-catenin axis and acts as a therapeutic target in ovarian cancer
Prognostic values of S100 family members in ovarian cancer patients
Long noncoding RNA C17orf91 is a potential prognostic marker and functions as an oncogene in ovarian cancer
DNA methylation-based profiling reveals distinct clusters with survival heterogeneity in high-grade serous ovarian cancer
Quantifying Patterns in Mortuary Practices: An Application of Factor Analysis and Cluster Analysis to Data From the Taosi Site, China
The prognostic significance of anti-angiogenesis therapy in ovarian cancer: a meta-analysis
Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience
Patients with low nicotinamide N-methyltransferase expression benefit significantly from bevacizumab treatment in ovarian cancer
Development and validation of SIRT3-related nomogram predictive of overall survival in patients with serous ovarian cancer
SCIPAC: quantitative estimation of cell-phenotype associations
The prognostic value of ITGA and ITGB superfamily members in patients with high grade serous ovarian cancer
Gene signature characteristic of elevated stromal infiltration and activation is associated with increased risk of hematogenous and lymphatic metastasis in serous ovarian cancer
The epigenetic factor CHD4 contributes to metastasis by regulating the EZH2/β-catenin axis and acts as a therapeutic target in ovarian cancer
Prognostic values of S100 family members in ovarian cancer patients
Long noncoding RNA C17orf91 is a potential prognostic marker and functions as an oncogene in ovarian cancer
DNA methylation-based profiling reveals distinct clusters with survival heterogeneity in high-grade serous ovarian cancer
Quantifying Patterns in Mortuary Practices: An Application of Factor Analysis and Cluster Analysis to Data From the Taosi Site, China
The prognostic significance of anti-angiogenesis therapy in ovarian cancer: a meta-analysis
Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience
Patients with low nicotinamide N-methyltransferase expression benefit significantly from bevacizumab treatment in ovarian cancer
Development and validation of SIRT3-related nomogram predictive of overall survival in patients with serous ovarian cancer
SCIPAC: quantitative estimation of cell-phenotype associations
The prognostic value of ITGA and ITGB superfamily members in patients with high grade serous ovarian cancer
Gene signature characteristic of elevated stromal infiltration and activation is associated with increased risk of hematogenous and lymphatic metastasis in serous ovarian cancer